The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

A new Idaho law that goes into effect in January reforms pharmacy benefit managers to increase transparency and cut ...

The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug prices on behalf of insurers, claiming they are illegally maximizing profits ...

The Federal Trade Commission's administrative complaint follows an interim report from the agency regarding PBM practices.

In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...

PBMs have been under fire for years for alleged profiteering and anticompetitive conduct, but efforts to regulate the industry at the federal level have stalled in Congress.

The 2024 Pharmacy Benefit Manager Customer Satisfaction Report published ... offers decision makers powerful comparative intelligence to help in the selection and management of services provided by ...

At issue is a report released by the FTC in July called: “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug ...

As prescription drug costs remains a significant, and largely bipartisan, issue for state and federal legislators, we ...

Instead of tackling the root causes, these price-setting boards could exacerbate the dominance of pharmacy benefit manager (PBM) owned pharmacies at the expense of community pharmacies.

Over the past decade, employers, HMOs, health care insurers, and various government entities have turned to pharmacy benefit management companies (PBMs) to help control their drug budgets.

Kerri Tanner, Pharm.D., the chief pharmacy officer of PayerAlly, says payers are looking for ways to rein in the escalating costs of specialty pharmacy drugs beyond the traditional techniques used by ...